ConductScience.org, home

Gene · 23526

ARHGAP45: Rho GTPase activating protein 45

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. ARHGAP45: Rho GTPase activating protein 45. Genes, record 23526. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/23526

On this page

Gene

Symbol
ARHGAP45
HGNC
Name
Rho GTPase activating protein 45
HGNC
NCBI Gene ID
23526
NCBI Gene
HGNC ID
HGNC:17102
HGNC
Ensembl
ENSG00000180448
NCBI Gene
Aliases
HA-1, HLA-HA1, HMHA1, KIAA0223
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q92619Rho GTPase-activating protein 451,1362Ensembl, GeneID, HGNC

Source UniProt

Patents24

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1449153Q92619Espacenet
EP 4641201 A22025-10-294663Q92619Espacenet
JP 2025147176 A2025-10-061036Q92619Espacenet
JP 2025529142 A2025-09-045519Q92619Espacenet
US 12371689 B22025-07-295519Q92619Espacenet
JP 2025517969 A2025-06-124663Q92619Espacenet
JP 2025508834 A2025-04-1024Q92619Espacenet
JP 2025028160 A2025-02-281036Q92619Espacenet
KR 1020250010750 A2025-01-211036Q92619Espacenet
US 12195515 B22025-01-143Q92619Espacenet

1 to 10 of 24

See all 24 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,059

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleARHGAP45 papersNewest fiscal year
P30CA021765Cancer Center Support Grant (CCSG)162025
P01CA018029Adult Leukemia Research Center112025
P30CA015704Cancer Center Support Grant62025
R35GM119774Real-time tracking of virus evolution for vaccine strain selection and epidemiological investigation62025
U19AI057266Vaccine and Infection Induced Immunity in the Young and Aged62025
P01AI089618Structure-function analysis of infection- and vaccine-induced B-cell repertoires52025
P30CA016672Cancer Center Support Grant42025
U24AG021886National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)42025
ZIADK031117Development of Drugs Acting at Adenosine Receptors42025
P30AI060354Harvard University Center for AIDS Research32025

1 to 10 of 1,059Source NIH's project files

See all 1,059 nih grants

Papers2,040

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Associations between brain phenotypes and temporomandibular disorders: An integrative multi-omics investigation.Cranio202642731980PubTator, text miningPubMed
First detection and transatlantic introduction of Influenza A(H3N2) subclade K (J.2.4.1) into Ecuador: insights from genomic sentinel surveillance.Front Public Health202642601999PubTator, text miningPubMed
Emergence and Genomic Characterisation of Influenza Virus A(H3N2) Subclade K in Saudi Arabia: Dominant Circulation With Fixed HA1 Substitutions and High-Frequency HA-NA Clade Association, 2025-2026.J Med Virol202642592671PubTator, text miningPubMed
Residue dissipation and dietary risk assessment of penconazole, bupirimate and its metabolite ethirimol in grapes using UPLC-MS/mS.J Environ Sci Health B202642535711PubTator, text miningPubMed
Genetic and health determinants of cancer risk in Bangladeshi and Pakistani individuals in the UK.Nat Commun202642315506PubTator, text miningPubMed
A novel self-amplified RNA vaccine co-expressing NA and HA1 delivered by Salmonella confers potent protection against H9N2 influenza in chickens.Poult Sci202642096905PubTator, text miningPubMed
Epigenomic subtypes of late-onset Alzheimer's disease reveal distinct microglial signatures.Acta Neuropathol202641733741PubTator, text miningPubMed
Current and emerging maintenance strategies after stem cell transplantation in children and adolescents with acute leukemias.Mol Ther Oncol202641716469PubTator, text miningPubMed
Management of Tithonia diversifolia (hemsl.) A. gray with herbicides as a strategy to reduce biological invasion of the species.J Environ Sci Health B202641689824PubTator, text miningPubMed
Metal-ion mediated photolytic regulation of diphenylalanine stability: Implications for prebiotic chemical evolution.iScience202641537004PubTator, text miningPubMed

1 to 10 of 2,040

See all 2,040 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/23526

GET https://conductscience.org/api/genes/v1/23526/patents?page=2